Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $50.1K | $30.1K | $55.1K | $475.3K | $1.5M | $2.4M | $4.1M | $5.1M |
| Cost of revenue | $15.0K | $55.5K | $44.0K | $330.0K | $653.3K | $1.1M | $1.3M | $2.3M |
| Gross profit | $35.1K | −$25.4K | $11.1K | $145.2K | $877.0K | $1.7M | $2.8M | $2.8M |
| Gross margin | 70.0% | -84.4% | 20.2% | 30.6% | 57.3% | 69.5% | 68.7% | 55.1% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$255.2K | −$1.6M | −$448.4K | −$9.9M | −$1.2M | −$715.2K | $81.2K | −$867.2K |
| EBITDA | −$1.5M | −$1.9M | −$1.7M | −$10.1M | −$1.0M | −$3.0M | $301.7K | −$586.1K |
| Net income | −$2.1M | −$3.1M | −$10.1M | −$15.6M | −$5.5M | −$9.8M | −$5.6M | −$7.8M |
| Net margin | -4105.6% | -10232.0% | -18336.3% | -3284.3% | -359.0% | -407.2% | -135.4% | -153.2% |
| EPS (diluted) | -0.50 | -0.58 | -1.08 | -1.36 | -0.45 | -0.79 | -0.44 | -0.62 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds MSSV.
No tracked institution reports a position in MSSV as of their last filing.
| Execution date | Ratio |
|---|---|
| 2002-09-26 | 1-for-20reverse |
No one on the platform has traded MSSV yet.
| $118638 |
| — |
| GGBBFLXRandCo, Inc. | $0.00 | +0.00% | $82283 | — |
| HGGGQhhgregg, Inc. | $0.00 | +500.00% | $33370 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× sales vs its 0.4× historical median P/S.
Fair value ≈ $0.16 · price $0.03 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$MSSV This now trades as RMTG. It’s an OTC delisted. Been watching this for a bit. Curious to see if this has any impact on price. Volume has been all but dead. You never know…
View on StockTwits ↗$MSSV I have a feeling I’m going to pop in here one day and see it trading above $1.00. Continued growth but flying under the radar. $RMTG
View on StockTwits ↗$MSSV 10-Q just hit! $793,329 in revenue last quarter which is 3.2M if annualized https://x.com/stockpicksnyc/status/1824068336709181926?s=46 Also 2.4M in annual revenue for 2023 (AUDITED) & SEC Reporting Their 4 main sources of revenue is from the following: • Patient procedures are the treatments GSCG is offering at its clinics • Training - GSCG offers a Stem Cell & Exosomes Certification Program where physicians attending pay for the training sessions upfront and receive all the material and certificate upon completion • Products-Physicians can order SVF Kits through GSCG, which includes EC Certificate from Institute for Testing and Certificating, Inc. SVT Kits are paid for upfront and shipped from a third party directly to physicians. Transfer of control is when the product is shipped, which is when revenue is recognized. • Equipment- Physicians can order equipment through GSCG, which includes a warranty from the manufacturer of equipment. Equipment is paid for upfront……
View on StockTwits ↗$MSSV insane how big this OTC company is. Heres a video of just 1 location of many. Market cap under 1M🫨 Video here: https://x.com/stockpicksnyc/status/1823747434561864062?s=46 They have locations in: USA, Turkey, Argentina, Belgium, Uzbekistan, Indonesia, Mexico, Portugal, Dominican Republic, Dubai
View on StockTwits ↗$MSSV News out today!! Launch of Revolutionary New Line of Peptides https://x.com/stockpicksnyc/status/1823346628306010249?s=46 $MSSV Cellgenic new peptide line includes: •Healing and Recovery •Anti-Aging and Skin Health •Metabolic and Longevity •Growth Hormone and Body Composition •Weight Management and Diabetes •Aesthetic and Sexual Health
View on StockTwits ↗$MSSV is MaSSiVe! You can see a lot information of their facilities/clinics when you search them on Google List of the locations pulled from the recent 10-K in pictures. Also pic of just 1 of locations instagram See here: https://x.com/stockpicksnyc/status/1822998356165112037?s=46 Massive company with locations around the world •Turkey🇹🇷 •Belgium🇧🇪 •Dominican Republic🇩🇴 •Uzbekistan🇺🇿 •Argentina🇦🇷 •Indonesia🇮🇩 •Mexico🇲🇽 •Portugal🇵🇹 •Miami USA🇺🇸 •Dubai🇦🇪 Also video attached showing a lot of their licensed clinics/facilities, staff and more!
View on StockTwits ↗$MSSV is a massive stemcell co with licensed facilities/clinics worldwide including: •Istanbul, Turkey🇹🇷 •Buenos Aires, Argentina🇦🇷 •Belgium🇧🇪 •Jakarta, Indonesia🇮🇩 •Cancun, Mexico🇲🇽 •Lisbon, Portugal🇵🇹 •Tashkent, Uzbekistan🇺🇿 •Dominican Republic🇩🇴 •Miami USA🇺🇸 •Dubai, United Arab Emirates🇦🇪 And more!! See here: https://x.com/stockpicksnyc/status/1822984956437475470?s=46 The best part is that the current market cap of $MSSV is 1M!!! It is a relatively unknown ticker starting to get noticed for the first time!!
View on StockTwits ↗$MSSV looking really good here •2M in Revenue •9 subsidiaries •Stemcell •26 locations •Audited co •SEC reporting Under 1M market cap😮 11M float👀 Unknown ticker but the word spreading fast with mentions already from SuperRobotOTC, OnlyCrownKing, Chairman_DN, ChaseMacTrades, cdntradegrljenn, OTC_Quinten, HulkInvestments, CrossStocks It’s only a matter of time until more investors discover this ticker and somebody hits that launch button. This company is just massive! DD on the way!! https://x.com/stockpicksnyc/status/1822979057635450992?s=46
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.